Publications by authors named "Samarina Musaad"

Claim this Profile
I
In vitro diagnostic devices need a robust regulatory framework.
Geoffrey Ce Herd, Samarina Ma Musaad

N Z Med J· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Connectivity for point-of-care testing results: a call for change.
Samarina Ma Musaad, Vanessa Buchan, Geoff Herd

N Z Med J· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care testing performed by healthcare professionals outside the hospital setting: consensus based recommendations from the IFCC Committee on Point-of-Care Testing (IFCC C-POCT).
Adil I Khan, Busadee Pratumvinit, Ellis Jacobs, Gerald J Kost, Heba Kary, Samarina Musaad

Clin Chem Lab Med· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-Care Testing in Rural and Remote Settings to Improve Access and Improve Outcomes: A Snapshot of the New Zealand Experience.
Geoffrey C E Herd, Samarina M A Musaad

Arch Pathol Lab Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-Care Testing and Equity.
Samarina M A Musaad

Arch Pathol Lab Med· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A three-way comparison of glycated haemoglobin: are results from the three platforms interchangeable?
Samarina Ma Musaad, George Chan, Campbell Kyle

N Z Med J· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care testing governance in New Zealand through the lens of quality: an update on a national regulatory framework.
Samarina Ma Musaad, Geoffrey Ce Herd

N Z Med J· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HbA screening in the community: Lessons for safety and quality management of a point of care programme.
Timothy Kenealy, Geoffrey Herd, Samarina Musaad, Susan Wells

Prim Care Diabetes· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization of Reflex Testing for Direct Bilirubin in the Early Recognition of Biliary Atresia.
Leo Lam, Samarina Musaad, Campbell Kyle, Stephen Mouat

Clin Chem· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical governance and point-of-care testing at health provider level.
Geoffrey Herd, Samarina M A Musaad

N Z Med J· July 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care testing: High time for a dedicated National Adverse Event Monitoring System.
Samarina M A Musaad, Shoukat Ali Khan, Geoff Herd

Clin Biochem Rev· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Point-of-care testing governance in New Zealand: a national framework.
Samarina M A Musaad, Geoff Herd

N Z Med J· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rheumatoid factor measurement--continuing problems 70 years after discovery.
Rohan Ameratunga, Samarina Musaad, Claudia Sugrue, Campbell Kyle

Clin Rheumatol· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of 2 human chorionic gonadotropin assays as tumor markers assays.
Stephen Andrew du Toit, Johannes Bouwhuis, Margaret Matson, Samarina Musaad, James S Davidson

Clin Chem· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extreme hyperalphalipoproteinaemia in a patient with a solitary paraspinal lipoma.
Samarina Musaad, Ken Robertson, Michael W Clarke, Amanda J Hooper, Gary French

Ann Clin Biochem· January 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fetal fibronectin assay may reduce management cost of preterm labour: an interval analysis.
Samarina M A Musaad, Louise C Melson, Ross D Boswell

Pathology· October 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of the impact of introducing fetal fibronectin assay in the management of preterm labour at Middlemore Hospital, New Zealand.
Samarina M A Musaad, C Louise Melson, D Ross Boswell

Pathology· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis